-+ 0.00%
-+ 0.00%
-+ 0.00%
Boston Scientific Approves 2026 Global Restructuring Program; Plans Intends To Cut Headcount;. Expects ~$700M - $800M As Pre-Tax Charges; Plan Expected To Reduce Annual Pre-Tax Expenses by $500M
Share
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/885725/000088572526000049/bsx-20260721.htm

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending